Lataa...
Anti-RNPC3 Antibodies as a Marker of Cancer-Associated Scleroderma
INTRODUCTION: Prior studies have demonstrated an increased risk of cancer-associated scleroderma in patients with RNA polymerase III (POL) autoantibodies and in patients negative for anti-centromere (CENP), anti-topoisomerase-1 (TOPO), and anti-POL antibodies (referred to as CENP/TOPO/POL (CTP)-Nega...
Tallennettuna:
| Julkaisussa: | Arthritis Rheumatol |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5449218/ https://ncbi.nlm.nih.gov/pubmed/28217959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.40065 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|